RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000083.xml
Synlett 2008(9): 1353-1356
DOI: 10.1055/s-2008-1072750
DOI: 10.1055/s-2008-1072750
LETTER
© Georg Thieme Verlag Stuttgart · New York
A Cycloaddition Strategy for Use toward Berkelic Acid, an MMP Inhibitor and Potent Anticancer Agent Displaying a Unique Chroman Spiroketal Motif
Weitere Informationen
Received
8 February 2008
Publikationsdatum:
07. Mai 2008 (online)
Publikationsverlauf
Publikationsdatum:
07. Mai 2008 (online)
Abstract
A kinetically controlled diastereoselective cycloaddition between a chiral enol ether and an ortho-quinone methide (o-QM) produces a chroman spiroketal motif that is found in the core of berkelic acid, a novel matrix metalloproteinase (MMP) inhibitor and potent anticancer agent. The transformation lays the groundwork for preparation of future inhibitors aimed at distinguishing among the active sites of the twenty-three known MMP. Experimental findings suggest that the stereochemistry that emerges from cycloaddition is opposite that which results from thermodynamic ketalization.
Key words
o-quinone methide - chroman spiroketal - berkelic acid - diastereoselective synthesis - MMP - anticancer agent - ketalization
- 1
Stierle AA.Stierle DB.Kelly K. J. Org. Chem. 2006, 71: 5357 - 2
Wasserman ZR. Chem. Biol. 2005, 143 - 3
Overall CM.Kleifeld O. Br. J. Cancer 2006, 94: 941 - 4
Itoh Y.Nagase H. Essays Biochem. 2002, 38: 21 - 5
Zucker S.Cao J.Chen WT. Oncogene 2000, 19: 6642 - 6
Engel CK.Pirad B.Schimanski S.Kirsch R.Habermann J.Kingler O.Schlotte V.Weithmann KU.Wendt KU. Chem. Biol. 2005, 181 - 7
Petasis NA.Lu S. J. Am. Chem. Soc. 1995, 117: 6394 - 8
Mejorado LH.Hoarau C.Pettus TRR. Org. Lett. 2004, 6: 1535 -
9a
Selenski C.Pettus TRR. J. Org. Chem. 2004, 69: 9196 -
9b
Selenski C.Mejorado LH.Pettus TRR. Synlett 2004, 1101 - 10
Zhou J.Snider BB. Org. Lett. 2007, 9: 2071